In this video from the 2014 ASH Annual Meeting, Dr. Röllig discusses the results of the SORAML trial that tested sorafenib in patients with acute myeloid leukemia.
Christoph Röllig, MD
Advertisement
Articles by Christoph Röllig, MD
Advertisement
Latest Updated Articles
- Sorafenib Demonstrates Activity in AML
December 9th 2014
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Nivolumab/AVD in Untreated Hodgkin Lymphoma
2
NCCN Guidelines Add Novel Therapeutics to First-Line TNBC Armamentarium
3
Defining Molecular Pathways Across Neuroendocrine Disease States
4
Comparison of the 3 Most Commonly Used Modified PD-1 Inhibitors Plus Chemotherapy in Inoperable Wild-Type Non–Small Cell Lung Cancer
5